Anbio Biotechnology (NNNN) Total liabilities 2023–2025
Anbio Biotechnology (NNNN) total liabilities at each fiscal year-end, per SEC filings.
$87,836FY2025 · since FY2023: $993,060 → $87,836
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $87,836 | -94.9% |
| FY2024 | $1.7M | +74.2% |
| FY2023 | $993,060 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice